Skip to main content Accessibility help
×
Home

Susceptibility of E. coli, P. aeruginosa, S. aureus and S. epidermidis to Different Bismuth Compounds.

  • Alejandro L. Vega-Jiménez (a1), Edgardo Berea-Montes (a2) and Argelia Almaguer-Flores (a1)

Abstract

Bismuth has been used as an antimicrobial agent for treating gastrointestinal disorders, and has been used in the eradication of Helicobacter pylori. The aim of the present study was to analyze the antimicrobial activity of different Bi compounds against opportunistic pathogens. Ten bismuth compounds were tested with three different concentrations (60, 30 and 10%), against pure cultures of the following bacterial strains: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus epidermidis. The results show that Bismuth subsalicylate, Bismuth trioxide and Bismuth subgallate had a good antibacterial activity however, Bismuth subsalicylate was the most effective in the inhibition of the four bacterial strains tested. In this study we confirm the antibacterial properties of Bi-based compounds for other bacteria than H. pylori.

Copyright

References

Hide All
1. Kirk, R.E. and Othmer, D.F.. Encyclopedia of Chemical Technology. 4rd Ed. 1994. New York, NY: Chichester, Wiley.
2. Hernandez-Delgadillo, M.. Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. International Journal of Nanomedicine 2012:7 21092113.
3. Figueroa-Quintanilla, D.. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med. 1993; 328(23):16531658.
4. Bierer, D.W.. Bismuth subsalicylate: history, chemistry, and safety. Rev. Infect. 1990. Dis. 12(Suppl. 1):S3–S8.
5. Marshall, B.J.. GI drug column. The use of bismuth in gastroenterology. Am. J. Gastroenterol. 1991.86:1625.
6. Veldhuyzen van Zanten, S.J.O and Sherman, P. M.. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonnuclear dyspepsia: a systematic overview. Can. Med. Assoc. J. 1994.150:177185.
7. DuPont, H.L. and Ericsson, C.D.. 1990. Use of bismuth subsalicylate for the prevention of travelers’ diarrhea. Rev. Infect. Dis. 12(Suppl. 1):S64–S67
8. McNulty, C.A.M. and Gearty, J.C.. Campylobacter pyloridis and associated gastritis: investigator blind, placebo-controlled trial of bismuth subsalicylate and eryth-romycin ethylsuccinate. Br Med J 1986;293:645–9
9. Lanza, F.L. and Skoglund, M.L.. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori, a placebo-controlled, ran-domized study. Am J Gastroenterology 1989;9:1060–4
10. Mora, L.T.A.. Hemostasia con bismuto. Revista ADM. 2003;(3):9094
11. Manhart, M.D.. In vitro Antimicrobial Activity of Bismuth Subsalicylate and Other Bismuth Salts. Reviews of Infectious Diseases, Vol. 12: (Supp.1).1990) pp. S11S15
12. Dittes, U. and Keppler, B. K.. Overview on bismuth (III) and bismuth (V) complexes with activity against Helicobacter pylori. Coord. Chem. Rev. 1997.163:345364.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed